UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 9, 2022
graphic
TRANSACT TECHNOLOGIES INC
(Exact name of registrant as specified in its charter)

Delaware
0-21121
06-1456680
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. employer identification no.)

One Hamden Center
 
2319 Whitney Avenue, Suite 3B, Hamden, CT
06518
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code: (203) 859-6800

(Former Name or Former Address, if Changed Since Last Report):  Not applicable.

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.01 per share
TACT
NASDAQ Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 2.02 Results of Operations and Financial Condition.

The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K.  Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On March 9, 2022, TransAct Technologies Incorporated issued a press release announcing its financial results for the quarter ending December 31, 2021.  A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d)            Exhibits
 
Press Release dated March 9, 2022 of TransAct Technologies Incorporated
     
 
104
Cover page from this Current Report on Form 8-K, formatted in Inline XBRL






SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
       
TRANSACT TECHNOLOGIES INCORPORATED
 
     
By:
 
/s/ David B. Peters
 
 
 
David B. Peters
 
 
 
Vice President & Chief Accounting Officer
 

Date: March 9, 2022

Exhibit 99.1

TransAct Technologies Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

2021 Fourth Quarter Net Sales of $11.1 Million
Full Year FST Recurring Revenue of $7.4 Million, up 95% on a Year-Over-Year Basis
FST Paid Terminals Up 73% from December 31, 2020
Hamden, CT – March 9, 2022 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary operating results for the fourth quarter and full year ended December 31, 2021.

“2021 marked many important milestones for TransAct, including three consecutive quarters of over $2 million in recurring Food Service Technology (“FST”) revenue, which highlights our ongoing pivot to a consistent, reliable stream of revenue from our industry leading BOHA! solutions. We added 4,130 paid terminals during the year, an impressive number despite an incredibly difficult macro environment on both the demand and supply sides, and I could not be prouder of the team’s execution during these times,” said Bart C. Shuldman, Chairman and CEO of TransAct. “We continue to see strong demand for both our BOHA! products and our Epic series printers, with a noticeable uptick in international casino ordering as the world comes back online post-COVID-19 and pent-up demand around the world is beginning to take shape.”

Fourth Quarter 2021 Financial Highlights
Net Sales: Net sales for the fourth quarter of 2021 were $11.1 million, up 43% compared to $7.8 million for the fourth quarter of 2020.
FST Recurring Revenue: FST recurring revenue for the fourth quarter of 2021 was $2.1 million, up 124% compared to $0.9 million for the fourth quarter of 2020.
Gross Profit: Gross profit for the fourth quarter of 2021 was $4.4 million, resulting in gross margin of 39.7%, compared to gross profit of $2.4 million for the fourth quarter of 2020, which resulted in a 30.6% gross margin.
Operating loss: Operating loss for the fourth quarter of 2021 was $(2.5) million, compared to operating loss of $(2.7) million for the fourth quarter of 2020.
Net loss: Net loss for the fourth quarter of 2021 was $(0.7) million, or $(0.07) net loss per diluted share, based on 9.8 million weighted average common shares outstanding. Net loss for the comparable 2020 period was $(1.9) million, or $(0.22) net loss per diluted share, based on 8.7 million weighted average common shares outstanding.
Adjusted net loss:  Adjusted net loss for the fourth quarter of 2021 was $(1.9) million, or $(0.19) net loss per diluted share compared to adjusted net loss for the fourth quarter of 2020 of $(1.9) million, or $(0.22) net loss per diluted share.
EBITDA: EBITDA loss was $(0.9) million for the fourth quarter of 2021, compared to an EBITDA loss of $(2.0) million for the fourth quarter of 2020.
Adjusted EBITDA loss: Adjusted EBITDA loss was $(2.1) million for the fourth quarter of 2021, compared to adjusted EBITDA loss of $(1.7) million for the fourth quarter of 2020.


Full Year 2021 Financial Highlights
Net Sales: Net sales for the 2021 year were $39.4 million, up 29.0% compared to $30.6 million for 2020.
FST Recurring Revenue: FST recurring revenue for the 2021 year was $7.4 million, up 95% compared to $3.8 million for 2020.
Gross Profit: Gross profit for 2021 was $15.3 million, resulting in gross margin of 38.7%, compared to gross profit of $12.9 million for 2020, which resulted in a 42.3% gross margin.
Operating loss: Operating loss for 2021 was $(9.5) million, compared to operating loss of $(8.2) million for 2020.
Net loss: Net loss for 2021 was $(4.1) million, or $(0.45) net loss per diluted share, based on 9.3 million weighted average common shares outstanding. Net loss for the comparable 2020 period was $(5.6) million, or $(0.72) net loss per diluted share, based on 7.8 million weighted average common shares outstanding.
Adjusted net loss:  Adjusted net loss for 2021 was $(7.5) million, or $(0.81) net loss per diluted share compared to adjusted net loss for 2020 of $(5.6) million, or $(0.72) net loss per diluted share.
EBITDA: EBITDA loss was $(5.2) million for 2021, compared to an EBITDA loss of $(6.8) million for 2020.
Adjusted EBITDA loss: Adjusted EBITDA loss was $(7.6) million for 2021, compared to adjusted EBITDA loss of $(5.9) million for 2020.
Paid Terminals:  Paid terminals in the market were 9,818 on December 31, 2021, compared to 5,688 on December 31, 2020, an increase of 73%.

2021 Fourth Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, March 9, 2022, beginning at 4:30 p.m. ET to discuss the Company’s preliminary fourth quarter and full year 2021 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 1-888-204-4368 and the conference ID number is 5263759 (domestic or international). Please call five minutes prior to the presentation to ensure that you are connected.

Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.

Conference Participation
The Company also announced its participation at the 34th Annual ROTH Conference on Monday, March 14, 2022. To arrange a 1-on-1 meeting with TransAct, please email oneononerequests@roth.com or contact your ROTH sales team representative to request. To learn more and submit a registration request, visit https://ibn.fm/ROTH2022Registration.


Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the ordinary earnings from operations excluded from the calculation of such measure; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net income (loss) and adjusted net income (loss) per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (for example, the forgiveness of the Company’s $2.2 million loan under the Paycheck Protection Program  (the “PPP Loan”) administered by the Small Business Administration (the “SBA”) pursuant to the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”) and the $1.5 million gain from the Employee Retention Credit pursuant to the CARES Act) that do not reflect the ordinary earnings of the Company’s operations.  The Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of the Company’s continuing business, as these measures adjust for special items that are not reflective of the normal results of the business.  These measures may be useful to an investor in evaluating the underlying operating performance of the Company’s business.  The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.

EBITDA is defined as net loss before net interest expense, income taxes, depreciation and amortization. A reconciliation of EBITDA to net loss, the most comparable GAAP financial measure, can be found attached to this release.

Adjusted EBITDA is defined as net loss before net interest expense, income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense, (2) the impact of the forgiveness of the PPP Loan by the SBA pursuant to the CARES Act and (3) the gain from the Employee Retention Credit pursuant to the CARES Act. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation to be a non-cash expense similar to depreciation and amortization, and the Company adjusts for the impact of the PPP Loan forgiveness and the gain from the Employee Retention Credit because the Company does not believe that these items reflect ordinary earnings of the Company from operations. A reconciliation of adjusted EBITDA to net loss, the most comparable GAAP financial measure, can be found attached to this release.

Adjusted net loss is defined as net loss adjusted for the impact of the forgiveness of the PPP Loan by the SBA pursuant to the CARES Act and the gain from the Employee Retention Credit pursuant to the CARES Act.  A reconciliation of adjusted net loss to net loss, the most comparable GAAP financial measure, can be found attached to this release.

Adjusted net loss per diluted share is defined as adjusted net loss divided by diluted shares outstanding.  A reconciliation of adjusted net loss per diluted share to net loss per diluted share, the most comparable GAAP financial measure, can be found attached to this release.


About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, POS automation, and oil and gas. The Company’s world-class products are designed from the ground up based on market and customer requirements and are sold under the BOHA! ™, AccuDate™, EPICENTRAL®, Epic, Ithaca® and Printrex® brands. TransAct has sold over 3.6 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.

TransAct®, BOHA!™, AccuDate™, Epic, EPICENTRAL®, Ithaca® and Printrex® are trademarks of TransAct Technologies Incorporated. ©2022 TRANSACT Technologies Incorporated. All rights reserved.

Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three months and full year ended December 31, 2021. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three months and audit for the full year ended December 31, 2021. During the course of the preparation of the Company’s consolidated financial statements and related notes as of and for the three months and full year ended December 31, 2021, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above.  As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.

This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.



Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", or "continue", or the negative thereof, or other similar words. All forward-looking statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic on our business, operations, financial condition, results of operations and capital resources, including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange rate fluctuations, volatility of and decreases in trading prices of our common stock and the availability of needed financing on acceptable terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures to find or develop alternative software products; our ability to successfully transition our business into the food service technology market; our ability to fully remediate a previously disclosed material weakness over internal control over financial reporting; risks associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from third parties; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars or tariffs; our ability to protect intellectual property; the effect of the United Kingdom’s withdrawal from the European Union; and other risk factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances, except as required by applicable law.

# # #
Investor Contact:
Bart Shuldman
Chairman and Chief Executive Officer
TransAct Technologies Incorporated
 
Ryan Gardella
ICR, Inc.
Ryan.Gardella@ircinc.com
 


- Financial tables follow –


TRANSACT TECHNOLOGIES INCORPORATED
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
(Preliminary and Unaudited)
 
         
   
Three Months Ended
   
Year Ended
 
   
December 31,
   
December 31,
 
   
2021
   
2020
   
2021
   
2020
 
   
(In thousands, except per share data)
 
                         
Net sales
 
$
11,123
   
$
7,763
   
$
39,386
   
$
30,595
 
Cost of sales
   
6,705
     
5,391
     
24,137
     
17,666
 
Gross profit
   
4,418
     
2,372
     
15,249
     
12,929
 
                                 
Operating expenses:
                               
Engineering, design and product development
   
1,992
     
1,506
     
7,475
     
5,703
 
Selling and marketing
   
2,549
     
1,259
     
7,658
     
6,144
 
General and administrative
   
2,362
     
2,268
     
9,626
     
9,255
 
     
6,903
     
5,033
     
24,759
     
21,102
 
Operating loss
   
(2,485
)
   
(2,661
)
   
(9,510
)
   
(8,173
)
                                 
Interest and other income (expense):
                               
Interest, net
   
(25
)
   
(11
)
   
(96
)
   
(52
)
Other, net
   
1,386
     
116
     
3,390
     
56
 
     
1,361
     
105
     
3,294
     
4
 
                                 
Loss before income taxes
   
(1,124
)
   
(2,556
)
   
(6,216
)
   
(8,169
)
Income tax benefit
   
389
     
638
     
2,071
     
2,539
 
Net loss
 
$
(735
)
 
$
(1,918
)
 
$
(4,145
)
 
$
(5,630
)
                                 
Net loss per common share:
                               
Basic
 
$
(0.07
)
 
$
(0.22
)
 
$
(0.45
)
 
$
(0.72
)
Diluted
 
$
(0.07
)
 
$
(0.22
)
 
$
(0.45
)
 
$
(0.72
)
                                 
Shares used in per share calculation:
                               
Basic
   
9,848
     
8,704
     
9,298
     
7,827
 
Diluted
   
9,848
     
8,704
     
9,298
     
7,827
 
                                 


SUPPLEMENTAL INFORMATION – SALES BY MARKET:
(Preliminary and Unaudited)
 
   
Three months ended
   
Year ended
 
   
December 31,
   
December 31,
 
   
2021
   
2020
   
2021
   
2020
 
   
(In thousands)
 
                         
Food service technology
 
$
3,522
   
$
2,810
   
$
12,625
   
$
7,734
 
POS automation
   
1,217
     
989
     
4,825
     
3,770
 
Casino and gaming
   
4,934
     
2,679
     
15,302
     
10,979
 
Lottery
   
-
     
-
     
-
     
817
 
Printrex
   
200
     
68
     
631
     
300
 
TransAct Services Group
   
1,250
     
1,217
     
6,003
     
6,995
 
Total net sales
 
$
11,123
   
$
7,763
   
$
39,386
   
$
30,595
 











































TRANSACT TECHNOLOGIES INCORPORATED
 
CONDENSED CONSOLIDATED BALANCE SHEETS
 
(Preliminary and Unaudited)
 
             
   
December 31,
   
December 31,
 
   
2021
   
2020
 
   
(In thousands)
 
Assets:
           
Current assets:
           
Cash and cash equivalents
 
$
19,457
   
$
10,359
 
Accounts receivable, net
   
7,593
     
3,377
 
Employee retention credit receivable
   
1,500
     
-
 
Note receivable
   
-
     
100
 
Inventories
   
7,720
     
11,286
 
Prepaid income taxes
   
137
     
2,409
 
Other current assets
   
738
     
644
 
Total current assets
   
37,145
     
28,175
 
                 
Fixed assets, net
   
2,684
     
1,950
 
Note receivable, net of current portion
   
-
     
1,584
 
Right-of-use asset
   
2,553
     
3,618
 
Goodwill
   
2,621
     
2,621
 
Deferred tax assets
   
5,141
     
2,939
 
Intangible assets, net
   
397
     
583
 
Other assets
   
400
     
777
 
     
13,796
     
14,072
 
Total assets
 
$
50,941
   
$
42,247
 
                 
Liabilities and Shareholders’ Equity:
               
Current liabilities:
               
Accounts payable
 
$
4,308
   
$
1,691
 
Accrued liabilities
   
3,894
     
3,665
 
Lease liability
   
789
     
837
 
Deferred revenue
   
805
     
504
 
Total current liabilities
   
9,796
     
6,697
 
                 
Long-term debt
   
-
     
2,173
 
Deferred revenue, net of current portion
   
186
     
111
 
Lease liability, net of current portion
   
1,781
     
2,864
 
Other liabilities
   
187
     
166
 
     
2,154
     
5,314
 
Total liabilities
   
11,950
     
12,011
 
                 
Shareholders’ equity:
               
Common stock
   
139
     
130
 
Additional paid-in capital
   
55,246
     
42,536
 
Retained earnings
   
15,573
     
19,718
 
Accumulated other comprehensive income (loss), net of tax
   
143
     
(38
)
Treasury stock, at cost
   
(32,110
)
   
(32,110
)
Total shareholders’ equity
   
38,991
     
30,236
 
Total liabilities and shareholders’ equity
 
$
50,941
   
$
42,247
 
                 



TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)


   
Three months ended
December 31, 2021
 
   
Reported
   
Adjustments(1)
   
Adjusted
Non-GAAP
 
Operating expenses
 
$
6,903
   
$
-
   
$
6,903
 
% of net sales
   
62.1
%
           
62.1
%
                         
Operating loss
   
(2,485
)
   
-
     
(2,485
)
% of net sales
   
(22.3
)%
           
(22.3
)%
                         
Interest and other income (expense)
   
1,361
     
(1,500
)
   
(139
)
Loss before income taxes
   
(1,124
)
   
(1,500
)
   
(2,624
)
Income tax benefit
   
389
     
330
     
719
 
Net loss
   
(735
)
   
(1,170
)
   
(1,905
)
Net loss per common share:
                       
Basic
 
$
(0.07
)
 
$
(0.12
)
 
$
(0.19
)
Diluted
 
$
(0.07
)
 
$
(0.12
)
 
$
(0.19
)


(1)
Adjustment includes $1,500 gain on recognition of the Employee Retention Credit that occurred in December 2021.


   
Three months ended
December 31, 2020
 
   
Reported
   
Adjustments(2)
   
Adjusted
Non-GAAP
 
Operating expenses
 
$
5,033
   
$
-
   
$
5,033
 
% of net sales
   
64.8
%
           
64.8
%
                         
Operating loss
   
(2,661
)
   
-
     
(2,661
)
% of net sales
   
(34.3
)%
           
(34.3
)%
                         
Interest and other income
   
105
     
-
     
105
 
Loss before income taxes
   
(2,556
)
   
-
     
(2,556
)
Income tax benefit
   
638
     
-
     
638
 
Net loss
   
(1,918
)
   
-
     
(1,918
)
Net loss per common share:
                       
Basic
 
$
(0.22
)
   
-
   
$
(0.22
)
Diluted
 
$
(0.22
)
   
-
   
$
(0.22
)


(2)
No adjustments.


TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)


   
Year ended
December 31, 2021
 
   
Reported
   
Adjustments(3)
   
Adjusted
Non-GAAP
 
Operating expenses
 
$
24,759
   
$
-
   
$
24,759
 
% of net sales
   
62.9
%
           
62.9
%
                         
Operating loss
   
(9,510
)
   
-
     
(9,510
)
% of net sales
   
(24.1
)%
           
(24.1
)%
                         
Interest and other income (expense)
   
3,294
     
(3,673
)
   
(379
)
Loss before income taxes
   
(6,216
)
   
(3,673
)
   
(9,889
)
Income tax benefit
   
2,071
     
330
     
2,401
 
Net loss
   
(4,145
)
   
(3,343
)
   
(7,488
)
Net loss per common share:
                       
Basic
 
$
(0.45
)
 
$
(0.36
)
 
$
(0.81
)
Diluted
 
$
(0.45
)
 
$
(0.36
)
 
$
(0.81
)


(3)
Adjustment includes (1) $2,173 gain on forgiveness of the PPP Loan that occurred in July 2021 and (2) $1,500 gain on recognition of the Employee Retention Credit that occurred in December 2021.



   
Year ended
December 31, 2020
 
   
Reported
   
Adjustments(4)
   
Adjusted
Non-GAAP
 
Operating expenses
 
$
21,102
   
$
-
   
$
21,102
 
% of net sales
   
69.0
%
           
69.0
%
                         
Operating loss
   
(8,173
)
   
-
     
(8,173
)
% of net sales
   
(26.7
)%
           
(26.7
)%
                         
Interest and other income
   
4
     
-
     
4
 
Loss before income taxes
   
(8,169
)
   
-
     
(8,169
)
Income tax benefit
   
2,539
     
-
     
2,539
 
Net loss
   
(5,630
)
   
-
     
(5,630
)
Net loss per common share:
                       
  Basic
 
$
(0.72
)
   
-
   
$
(0.72
)
Diluted
 
$
(0.72
)
   
-
   
$
(0.72
)


(4)
No adjustments.




TRANSACT TECHNOLOGIES INCORPORATED
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
(Preliminary and Unaudited)

   
Three Months Ended
   
Year Ended
 
   
December 31,
   
December 31,
 
   
2021
   
2020
   
2021
   
2020
 
   
(In thousands)
 
                         
Net loss
 
$
(735
)
 
$
(1,918
)
 
$
(4,145
)
 
$
(5,630
)
                                 
Interest expense, net
   
25
     
11
     
96
     
52
 
Income tax benefit
   
(389
)
   
(638
)
   
(2,071
)
   
(2,539
)
Depreciation and amortization
   
236
     
584
     
957
     
1,342
 
                                 
EBITDA
   
(863
)
   
(1,961
)
   
(5,163
)
   
(6,775
)
                                 
Share-based compensation expense
   
254
     
232
     
1,206
     
876
 
Forgiveness of the PPP Loan
   
-
     
-
     
(2,173
)
   
-
 
Gain on recognition of the Employee Retention  Credit
   
(1,500
)
   
-
     
(1,500
)
   
-
 
                                 
Adjusted EBITDA
 
$
(2,109
)
 
$
(1,729
)
 
$
(7,630
)
 
$
(5,899
)